Chinese Journal of Pharmaceuticals
|
2022, 53(12): 1810-1813
• Pharmaceutical Management & Information •
Consideration on Development and Regulation of Inhalation Dosage Forms in China
Full
Affiliations
- 1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100022
- 2.National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203
Published: 2022-12-10
doi: 10.16522/j.cnki.cjph.2022.12.019
Outline
袁利佳, 王健.
我国吸入制剂的研发应用现状与监管思考.
中国医药工业杂志,
2022
, 53
(12)
: 1810
-1813
.
DOI: 10.16522/j.cnki.cjph.2022.12.019
Lijia YUAN, Jian WANG.
Consideration on Development and Regulation of Inhalation Dosage Forms in China[J].
Chinese Journal of Pharmaceuticals,
2022
, 53
(12)
: 1810
-1813
.
DOI: 10.16522/j.cnki.cjph.2022.12.019
Year 2022 volume 53 Issue 12
80
15
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2022.12.019
- Receive Date:2022-09-30
- Online Date:2026-11-12
- Published:2022-12-10